— Know what they know.
Not Investment Advice

INVA NASDAQ

Innoviva, Inc.
1W: -2.9% 1M: -5.5% 3M: -5.1% YTD: +11.7% 1Y: +18.2% 3Y: +67.5% 5Y: +72.5%
$22.46
+0.26 (+1.17%)
 
Weekly Expected Move ±3.1%
$21 $21 $22 $23 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $1.7B mcap · 69M float · 1.05% daily turnover · Short 44% of daily vol

📊 Key Metrics

TTM
$424M
Revenue
+13.6% YoY
$504M
Net Income
+944.5% YoY
$181M
Free Cash Flow
-7.7% YoY
77.4%
Gross Margin
38.9%
Op. Margin
190.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE54.1%
ROA34.4%
ROIC5.9%

Valuation

P/E3.3
P/B1.2
EV/EBITDA3.8

Leverage

Debt/Equity0.23
Current Ratio14.64
Interest Cov.63.4x

Quality Scores

Piotroski F6/9
Altman Z4.39
Beneish M-1.93

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms